Abstract
LakePharma, a biologic-drugs contract service firm, and Twist Bioscience, a DNA synthesis provider, are combining services in antibody discovery and development. Under the agreement, LakePharma will have access to Twist’s antibody discovery and optimization platforms, including one that focuses on antibodies against G protein–coupled receptor targets. Twist will have access to LakePharma’s discovery and development services.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
